✦ LIBER ✦

Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience

✍ Scribed by Yutaka Shimazu; Kenji Notohara; Yasunori Ueda

Publisher: Carden Jennings Publishing
Year: 2009
Tongue: English
Weight: 287 KB
Volume: 89
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0289-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for poor treatment outcome

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

✍ Keun-Wook Lee; Jongyoun Yi; In Sil Choi; Jee Hyun Kim; Soo-Mee Bang; Dong-Wan Ki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 443 KB

LACE-conditioned autologous stem cell tr

LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre

✍ Jiří Pavlů; Holger W. Auner; Sarah Ellis; Richard M. Szydlo; Chrissy Giles; Alej 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a recognized treatment option for patients with relapsed diffuse large B-cell lymphoma. We have analysed 51 patients who underwent ASCT after LACE (lomustine (CCNU), cytarabine (Ara-C), cyclophosphamide, etoposide) con

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr